当前位置: 首页 > 期刊 > 《医学信息》 > 2016年第28期
编号:12960244
肿瘤标志物在肺癌辅助诊断中的应用(1)
http://www.100md.com 2016年7月16日 《医学信息》 2016年第28期
     摘要:目的 肺癌肿瘤标志物在肺癌诊断、复发、手术评估方面均有较高价值,本研究探讨5种血清肿瘤标志物神经原特异性烯醇化酶(NSE)、癌胚抗原(CEA)、癌抗原125(CA125)、细胞角蛋白19片段(CYFRA21-1)和鳞状细胞癌抗原(SCC)在肺癌辅助诊断中的应用价值,及敏感性和特异性最高的肿瘤标志物组合。方法 收集120例肺癌患者,80例健康人和98例肺部良性疾病患者血清。以上5种标志物水平均采用酶联免疫吸附实验(ELISA)检测。结果 肺癌患者的5种血清肿瘤标志物水平均明显高于非肿瘤组、健康组和良性疾病组,差异有统计学意义(P<0.01)。其中NSE在小细胞肺癌、CYFRA21-1、鳞癌抗原(SCC)在鳞癌中的水平明显高于其他类型的肺癌;NSE对小细胞肺癌检测的敏感性明显高于其他类型的肺癌; 以上5种血清癌标志物经组合后,敏感性明显高于任一单项癌标志物(P<0.01)。结论 5种血清肿瘤标志物对于肺癌的辅助诊断有一定的临床意义。

    关键词:肺肿瘤标志物;诊断学;肺癌
, http://www.100md.com
    Abstract:Objective Lung cancer tumor markers in lung cancer diagnosis and assessment of recurrence, surgery has a higher value,.This study of 5 kinds of serum tumor markers in diagnosis of lung cancer application, including the neuron-specific enolase (NSE) and carcinoembryonic Antigen (CEA) and cancer Antigen 125 (CA125) and Cytokeratin 19 fragment () and squamous cell carcinoma Antigen (SCC);Methods 120 cases of patients with lung cancer, 80 healthy and Sera of 98 patients with benign disease.Above 5 kinds of markers are made of Elisa experiments (ELISA) testing.Results 5 kinds of serum tumor markers in patients with lung cancer are significantly higher than the non-tumor group and healthy groups and benign disease group, a statistically significant difference (P<0.01). NSE in small cell lung cancer, CYFRA21-1 and squamous cell carcinoma Antigen (SCC) Squamous cell carcinomas were significantly higher than those in other types of lung cancer (P<0.01); Detection sensitivity of NSE for small cell lung cancer was significantly higher than other types of lung cancer (P<0.01); More than 5 kinds of serum tumor markers combination, sensitivity was significantly higher than any single cancer markers (P<0.01).Conclusion 5 kinds of serum tumor markers for lung cancer diagnosis has clinical significance. NSE can be used as a marker for detection of small cell lung cancer;CEA +CYFRA21-1+SCC can be used to inspect non-small cell lung cancer with combination of markers. CYFRA21-1+SCC can be used to inspect combinations of markers in lung squamous cell carcinoma.
, http://www.100md.com
    Key words:Lung tumor markers; Diagnosis;Lung cancer

    随着肿瘤发病率上升及患病年轻化,肿瘤的早期诊断和治疗受到了前所未有的重视。肿瘤标志物的研究与应用对肿瘤的早期诊断治疗开创了新领域。肿瘤患者血清中肿瘤标志物的量发生改变时,能够揭示某种肿瘤的存在[1]。肿瘤标志物在肿瘤普查、诊断、判断预后和转归,评价疗效等方面具有较大实用价值。在临床上肿瘤标志物已成为肿瘤患者的重要检查指标[2]。因此,我们对目前应用于临床检测肺癌的5种血清肿瘤标志物(CEA、NSE、CYFRA21-1、SCC、CA125)进行了研究,目的是评价其在肿瘤诊断中的价值,并选择最理想的标志物组合以提高检测肺癌的敏感性。

    1资料与方法

    1.1一般资料

    1.1.1健康成人组收集我院体检科健康成人80例,其中男51例,女29例;平均年龄41岁。

    1.1.2良性疾病组均为我院呼吸科、感染内科2014年1月~7月住院患者。肺结核患者58例,其中男35例,女23例;平均年龄36岁,一般肺感染患者40例,其中男23例,女17例;平均年龄65岁。, http://www.100md.com(韩宾)
1 2下一页